Skip to content

Modulation of Cortical Gamma Synchrony in Stroke

Assessment and Modulation of Cortical Gamma Synchrony to Predict and Improve Stroke Recovery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05830617
Acronym
GAMMASTROKE
Enrollment
220
Registered
2023-04-26
Start date
2021-03-23
Completion date
2024-03-23
Last updated
2023-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

tACS, gamma synchrony

Brief summary

In the last decades, the research in neuroimaging-informed stroke prognosis and treatment has had a little clinical impact, often because of the costs of bringing complex procedures to the bedside. Cerebral stroke remains the leading cause of disability, with 65% of survivors chronically impaired at 6 months. Gamma synchrony (GS) is a fundamental mechanism of cortical function and can be estimated and modulated in a simple, inexpensive, and reliable way. It has provided valuable and cost-effective guidance in several neuropsychiatric conditions. In previous studies, we developed simple yet robust methods for assessing and manipulating GS and proved its relationship with clinical impairment in preliminary data. The aim of the present project is to predict and improve stroke recovery by leveraging cortical mapping and modulation of GS via transcranial alternating current stimulation (tACS), a safe and inexpensive technique. The project capitalizes on technology readily available to the Italian national health system.

Detailed description

The project will consist of 3 Work Packages (WPs): * The aim of WP1 is to map the relationship between GS and clinical outcomes with EEG. * The aim of WP2 is to translate GS assessment and modulation to bedside. * The aim of WP3 is to modulate GS to improve rehabilitation outcomes.

Interventions

DEVICEreal tACS

The effect of transcranial alternating current stimulation (tACS) will be investigated in WP3. Patients will undergo standard intensive rehabilitation plus gamma tACS for two weeks.

DEVICEsham tACS

In WP3, patients will undergo standard intensive rehabilitation plus sham tACS for two weeks.

Sponsors

Campus Bio-Medico University
CollaboratorOTHER
IRCCS San Camillo, Venezia, Italy
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

The participants in this study will be 140 stroke patients rehabilitated at IRCCS San Camillo hospital. 80 will participate in the WP1 and the WP2, while 60 will participate in the WP3 study. In WP1, data will also be collected on 80 healthy volunteer participants, approximately the same age as the patients. Inclusion Criteria (healthy participants) \- no neurological or psychiatric disorder Inclusion Criteria (patients) * right or left hemisphere damage * unilateral stroke * no comorbidities with psychiatric disorders

Exclusion criteria

(general): * Diagnosis of epilepsy or family history up to the second degree with it * Episodes of febrile convulsions or recurrent fainting * Head trauma * Presence of surgical clips or metal implants in the head * Diagnosis of heart disease * Presence of a cardiac pacemaker or artificial heart valve * Presence of hearing aids/prostheses * Hearing problems or tinnitus * Vision problems not corrected with lenses (such as color blindness) * Taking tricyclic antidepressant medications * Taking neuroleptic medications * Diagnosis of headache or migraine

Design outcomes

Primary

MeasureTime frameDescription
Gamma synchrony Work Package 1 (WP1)baselineGamma synchrony will be measured via exposure to amplitude-modulated 40Hz sounds (5 min, sequence of amplitude-modulated tones at 40 Hz, delivered via earplug binaurally). Gamma synchrony will be quantified as power of the EEG gamma band. Gamma synchrony will be measured at the baseline of the intervention (i.e., standard intensive rehabilitation at IRCCS S. Camillo Hospital)
Gamma synchrony Work Package 3 (WP3)baselineGamma synchrony will be measured via exposure to amplitude-modulated 40Hz sounds (5 min, sequence of amplitude-modulated tones at 40 Hz, delivered via earplug binaurally). Gamma synchrony will be quantified as power of the EEG gamma band. Gamma synchrony will be measured at the baseline of the intervention (i.e., standard intensive rehabilitation at IRCCS S. Camillo Hospital)
Gamma synchrony (reduced number of EEG sensors). Work Package 2 (WP2)baselineGamma synchrony will be measured via exposure to amplitude-modulated 40Hz sounds (5 min, sequence of amplitude-modulated tones at 40 Hz, delivered via earplug binaurally). Gamma synchrony will be quantified as power of the EEG gamma band. Gamma synchrony will be measured at the baseline of the intervention (i.e., standard intensive rehabilitation at IRCCS S. Camillo Hospital)

Secondary

MeasureTime frameDescription
Behavioral performance (response times). Work Package 1 (WP1)baselineParticipants' cognitive performance at neuropsychological tests will be measured. Behavioral performance will be measured in terms of response times (how fast the participants complete the task). Behavioral performance will be measured at the baseline of the intervention (i.e., standard intensive rehabilitation at IRCCS S. Camillo Hospital)
Behavioral performance (accuracy). Work Package 3 (WP3)baselineParticipants' cognitive performance at neuropsychological tests will be measured. Behavioral performance will be measured in terms of accuracy (% of correct responses). Behavioral performance will be measured at the baseline of the intervention (i.e., standard intensive rehabilitation at IRCCS S. Camillo Hospital)
Behavioral performance (response times). Work Package 3 (WP3)baselineParticipants' cognitive performance at neuropsychological tests will be measured. Behavioral performance will be measured in terms of response times (how fast the participants complete the task). Behavioral performance will be measured at the baseline of the intervention (i.e., standard intensive rehabilitation at IRCCS S. Camillo Hospital)
Behavioral performance (accuracy). Work Package 1 (WP1)baselineParticipants' cognitive performance at neuropsychological tests will be measured. Behavioral performance will be measured in terms of accuracy (% of correct responses). Behavioral performance will be measured at the baseline of the intervention (i.e., standard intensive rehabilitation at IRCCS S. Camillo Hospital)

Countries

Italy

Contacts

Primary ContactGiorgio Arcara
giorgio.arcara@hsancamillo.it0412207594

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026